[e-drug] Money is Mammon in pharmaceutical world - BM Hegde (The Hindu)

E-DRUG: Money is Mammon in pharmaceutical world - BM Hegde (The Hindu)
---------------------------------------------------------------------

http://www.thehindu.com/opinion/open-page/money-is-mammon-in-pharmaceutical-world/article4179010.ece
[Fix URL in browser if broken; Copied as Fair Use. DB]

THE HINDU 9th Dec 2012
Money is Mammon in pharmaceutical world
PROFESSOR B. M. HEGDE
The love of money is the root of all kinds of evil. - Jesus

Wall Street has three major players - pharmaceuticals, oil and banking. The first is the only one that has been growing at 20% a year in the last one decade or so. The pharmaceuticals lobby is thrice as big and powerful as that of oil, although oil is much bigger than drugs in total turnover! To understand how the industry works one must read the new book by two French medical specialists appointed by the former French President Nicolas Sarkozy to study the working of the drugs lobby in the country. Although the book is in French, Kim Wilsher of the The Guardian has written about this book and the interview with the authors on September 14, 2012.

The best part of the interview was the answer given by the first author: “There is nothing revolutionary in this book. This has all been known for some time.” I was happy as I was writing about this in India, the U.K. and the U.S. for at least four decades but to no avail. The powers that be do not seem to take notice, at least in India. The two authors, Professor Philippe Even, director of the prestigious Necker Institute, and Bernard Debre, a doctor and member of Parliament, feel that removing what they describe as superfluous and hazardous drugs from the list of those paid for by the French health service would save up to ‚EUR10bn (£8bn) a year. It would also prevent up to 20,000 deaths linked to the medication and reduce hospital admissions by up to 1,00,000, they claim.

The book, Guide to 4000 Useful, Useless or Dangerous Medicines, in all its 900 pages, looked at the effectiveness, risk, and the prohibitively high cost of the drugs. Among those which were completely useless the first rank was taken by STATINS, the most fashionable and doctor-friendly anti-cholesterol drug. The authors blacklisted a total of 58 drugs which included anti-inflammatory drugs, painkillers; cardiovascular drugs many of which are useless, anti-diabetics - many of them are dangerous to say the least - and the useless drugs for osteoporosis, contraception, muscular cramps and tobacco addiction! According to these specialists, roughly one half of the drugs prescribed by doctors in France are useless and many of them downright dangerous. The authors feel that the powerful companies keep these drugs moving for their own benefit.

Most of these drugs are produced in France. Professor Evans felt that the companies push these drugs on doctors who then push them on to patients. “The pharmaceutical industry is the most lucrative, the most cynical and the least ethical of all the industries,” he said. “It is like an octopus with tentacles that has infiltrated all the decision-making bodies, world health organisations, governments, parliaments, high administrations in health and hospitals and the medical profession,” he felt. “For the last 40 years, patients have been told that medicines are necessary for them, so they ask for them. Today, we have doctors who want to give people medicines and sick people asking for medicines. There’s nothing objective or realistic about this.”

The story is the same in India. The only difference is that the number of useless drugs sold here will run into hundreds, if not thousands. The Indian public have shown lukewarm response to my writings on the subject in the last four decades. Now that the information comes from the West, people might sit up and take note. That would be good for mankind as Oliver Wendell Holmes put it succinctly thus: “If the whole pharmacopeia were to be sunk to the bottom of the seas, that will be that much good for people and that much worse for the fishes.” How true indeed? There is no pill for every ill but there is definitely an ill following every pill!

How can we change all these? One would shudder to see this report in a recent issue of the prestigiousThe New England Journal of Medicine: “The global pharmaceutical industry has racked up fines of more than $11billion in the past three years for criminal wrongdoing, including withholding safety data and promoting drugs for use beyond their licensed conditions.

In all, 26 companies, including eight of the 10 top players in the global industry, have been found to be acting dishonestly. The scale of the wrongdoing, revealed for the first time, has undermined public and professional trust in the industry and is holding back clinical progress.”

A fine of $3 billion, imposed on the U.K.-based GlaxoSmithKline in July after it admitted to three counts of criminal behaviour in U.S. courts, was probably the highest paid so far in the history of pharmaceuticals. Nine other companies have had fines imposed, ranging from $420m on Novartis to $2.3bn on Pfizer since 2009, totalling over $11bn.

The be-all and end-all of life should not be to get rich, but to enrich the world.
- B.C. Forbes

(The writer is a former Professor of Cardiology, Middlesex Medical School, London,
and former Vice-Chancellor, Manipal University. Email: hegdebm@gmail.com)
----------
Dr Gopal Dabade,
57, Tejaswinagar,
Dharwad 580 002
Tel 0836-2461722
Cell (0)9448862270
www.jagruti.org
http://aidanindia.wordpress.com/
www.daf-k.cjb.net

E-DRUG: MSF is looking for a Medical Supply Pharmacist
--------------------------------------------------------------------

Effective 1 January 2013 the Public Health Department of Medecins Sans Frontieres is looking for a:

Medical Supply Pharmacist based in Amsterdam, the Netherlands

The overall purpose of Medecins Sans Frontieres (MSF) is to preserve life and alleviate suffering while protecting human dignity and seeking to restore the ability of people to make their own decisions. MSF accomplishes this through the provision of medical aid and a personal commitment to act as witness to events surrounding populations in danger. This work is essentially performed in periods of crisis, when a situation is no longer held in balance and the very survival of a population may be threatened. The underlying basis for realising its objectives is respect for medical ethics, humanistic ideals, human rights and international humanitarian law.

The Public Health Department (PHD) of the MSF Operational Centre Amsterdam (OCA) supports the overall purpose of MSF, providing medical and public health leadership for the organisation. The department is responsible for providing strategic direction and integrated advice on medical and public health issues to the field and headquarters. The PHD plays a key role in developing and maintaining the medical humanitarian identity and image of MSF-OCA, and in continuing to develop and improve intervention strategies so as to be relevant and effective.

The department is made up of a group of generalist Health Advisors (based in Amsterdam and Berlin) and medical and public health specialists (e.g., HIV/TB, laboratory, mental health, nutrition, paediatrics, surgery/anaesthesia, water/sanitation, etc. based in Amsterdam) so as to provide expert support in a range of fields. The Manson Unit, a medical unit based in MSF-UK, focuses on support to tuberculosis and epidemiology, including longer-term direct field support to overcome implementation challenges.

The Medical Supply Pharmacist post is situated in the Public Health Department in Amsterdam. The post-holder works in close collaboration with the MSF-OCA section pharmacist in the PHD and with the procurement pharmacist in the Logistics department.

Position within the organization:
The Medical Supply Pharmacist reports hierarchically directly to the Co-ordinator Medical Specialists, Public Health Department (Amsterdam) and receives functional support from the international pharmacist (Geneva).

Objective of the post:
The overall aim of this post is to provide expert advice and specialist support across MSF OCA operations and to colleagues within the Public Health Department on pharmaceutical and medical supply, as well as to assure, and continuously improve, the supply and management of pharmaceuticals and medical products supplied and used by MSF OCA.

Core responsibilities and tasks:
-Promote the vision of the PHD in the field of medical supply and pharmacy management;
-Initiate/develop an integral and coherent policy on medical supply and pharmacy management and develop protocols, training tools, etc to support it;
-Support implementation and follow up on the OCA consumption tool and medical supply guidelines in the field. Maintain up-to-date forecasting tools with relevant specialist (HIV/AIDS for ARV and PMTCT tool, TB and DR-TB, Nutrition, Vaccination, malaria) and support the field with implementation;
-Promote MSF Policies on Pharmacy and Medical Supply Management and develop strategies for implementation within OCA;
-Contribute as a key member of the OCA Medical Supply Working Group and coordinate with the Logistics Department to ensure medical supply management is consistent along all levels of the supply chain;
-Identify needs and support development of training on pharmacy management and medical supply for field pharmacists, and ensure knowledge transfer on policies, protocols, guidelines, etc.;
-Promote and support the role of the field pharmacist in OCA;
-Provide regular technical support to field regarding pharmaceutical issues including cold chain rupture, management of expired drugs, follow-up of procurement issues including quality alerts, advice regarding specific local purchase and donation requests; new item requests for green lists and review of standard drug lists; and
-Provide back-up for the Section Pharmacist while she/he is on leave or on a field support visit.
  
CANDIDATE CRITERIA
Education and experience:
-Qualified Pharmacist with current licensure/registration in a highly regulated country
-Field experience in low-resource contexts; MSF field experience a plus
-Strong background in medical supply and pharmacy management

Capacities and skills:
-Good written and oral communication skills, with the capacity to act as an adviser to colleagues and the field
-Must be able to visit and support projects at short notice, and willing to spend up to 30% of time in the field
-Strong interpersonal skills: innovative, able to mobilise/motivate and coach people
-Able to work under time pressure on various projects at a time
-Fluency in English and preferably French is required; Dutch is not necessary

WE ARE OFFERING
-A full time appointment (based on a 40-hour work week) for the year 2013 in Amsterdam , preferably as of January 1, 2013
-A gross monthly salary of a minimum €2,961 and a maximum of €4,230 depending on relevant professional work experience, for a full-time appointment
-A stimulating, professional working environment in an international organisation
-Attractive secondary benefits

INFORMATION AND APPLICATION
If you are interested in this post and would like additional information, please contact Debbie Cunningham (Coordinator of Medical Specialists) phone +31 (0) 20 520 8724

If you are interested in this position and believe that you fit the profile and meet the requirements, please send your application letter together with your CV before 23 December 2012 to officejobs@amsterdam.msf.org mentioning "Medical Supply Pharmacist" for the attention of Ms Jaline Wijkhuizen (Personnel Officer HQ). Please also mention where you read about this vacancy.